Monitoring Your Levels and Aging Gracefully
At a Glance
Once hypothyroidism is stabilized, TSH levels are typically checked annually. However, levothyroxine doses often need adjustments due to aging, pregnancy, weight changes, or new medications. For adults over 65, a slightly higher TSH is normal and helps avoid risks of overtreatment.
Once you have found a dose of levothyroxine that works for you, the goal shifts to long-term “maintenance.” While it might seem like a simple daily pill, your body’s need for thyroid hormone can change based on your age, your weight, and other medications you take.
The Long-Term Monitoring Schedule
For most patients who have achieved stable thyroid levels (a state called euthyroidism), the monitoring schedule becomes much less frequent [1].
- Initial Phase: Blood tests every 6 to 12 weeks until your dose is stabilized [1].
- Stable Phase: Once your dose is set, a TSH test is typically recommended once every 12 months [1].
Crucial Safety Warning: Pregnancy
Contact your doctor the moment you have a positive pregnancy test. Levothyroxine medication often needs immediate and significant adjustment to ensure healthy fetal brain development [2]. During pregnancy, your TSH must be monitored closely and kept below specific targets (often below 2.5 mIU/L) to protect both you and the baby [2].
Age Matters: The “Over 65” Shift
One of the most important recent changes in thyroid medicine is the understanding that “normal” TSH levels change as we get older.
- Natural Rising TSH: As you age, your TSH levels naturally rise. For someone over 65, a TSH between 4.5 and 7.0 mIU/L may be perfectly normal and healthy, whereas it would be considered “high” for a younger person [3][4].
- The Danger of Overtreatment: In older adults, being on too much thyroid medication (overtreatment) is often more dangerous than having a slightly high TSH [5]. Excess thyroid hormone can lead to:
- Individualized Targets: Current guidelines suggest that for many seniors, doctors should not start treatment unless the TSH is persistently above 7.0 or even 10.0 mIU/L [9][10].
Why Your Dose Might Need to Change
Even if you have been on the same dose for years, several factors can suddenly make that dose too high or too low:
- Weight Changes: Thyroid hormone is often dosed based on weight. If you lose a significant amount of weight, your current dose may become too high, leading to symptoms of an overactive thyroid [11][12].
- New Medications:
- Estrogen Therapy: Starting birth control or hormone replacement therapy (HRT) can increase the amount of “binding proteins” in your blood, often requiring a higher dose of thyroid hormone [13].
- Acid Reflux Meds: Proton Pump Inhibitors (PPIs) can change the acidity of your stomach, making it harder to absorb your thyroid pill [14].
- Other Meds: Certain antidepressants (like quetiapine) or iron and calcium supplements can also interfere with your levels [15][16].
When to Call the Doctor
Between your annual check-ups, you should alert your medical team if you notice signs that your dose may be off. Signs of too much hormone (overtreatment) include heart palpitations, feeling unusually hot, or sudden weight loss [17]. Signs of too little hormone (undertreatment) include returning fatigue, cold intolerance, or unexplained weight gain [18].
Common questions in this guide
How often should I check my TSH levels once they are stable?
Do normal TSH levels change as you get older?
Why would my levothyroxine dose need to change if I've been on the same dose for years?
What should I do if I get pregnant while on thyroid medication?
What are the signs that my thyroid medication dose is too high?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Now that my levels are stable, how often do we need to check my TSH? Should it be every 6 months or once a year?
- 2.Since I am over 65, what is my specific TSH target? Is it higher than the standard lab reference range?
- 3.I’m starting a new medication (like estrogen or a PPI)—does this mean we need to check my thyroid levels sooner than planned?
- 4.If I lose or gain a significant amount of weight, how soon should I have my TSH re-tested?
- 5.What are the early signs of 'overtreatment' I should watch for to ensure I'm not at risk for heart rhythm issues or bone loss?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (18)
- 1
Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient's Lifetime.
Duntas LH, Jonklaas J
Advances in therapy 2019; (36(Suppl 2)):30-46 doi:10.1007/s12325-019-01078-2.
PMID: 31485977 - 2
Update on therapeutic use of levothyroxine for the management of hypothyroidism during pregnancy.
Urgatz B, Poppe KG
Endocrine connections 2024; (13(3)).
PMID: 38190256 - 3
Reference intervals for thyroid hormones for the elderly population and their influence on the diagnosis of subclinical hypothyroidism.
Fu J, Wang Y, Liu Y, et al.
Journal of medical biochemistry 2023; (42(2)):258-264 doi:10.5937/jomb0-39570.
PMID: 36987412 - 4
Age-specific serum thyrotropin reference range for the diagnosis of subclinical hypothyroidism and its association with lipid profiles in the elderly population.
Ni W, Zhang M, Wang X, et al.
Scientific reports 2022; (12(1)):20872 doi:10.1038/s41598-022-24182-w.
PMID: 36463291 - 5
The ages and TSH values of patients being prescribed levothyroxine.
Jonklaas J, DeSale S
Therapeutic advances in endocrinology and metabolism 2020; (11()):2042018820937896 doi:10.1177/2042018820937896.
PMID: 32655852 - 6
Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis.
Kostopoulos G, Doundoulakis I, Antza C, et al.
Endocrine-related cancer 2021; (28(5)):325-335.
PMID: 33794503 - 7
Increased risk of osteoporosis among thyroid cancer survivors: the influence of postoperative levothyroxine therapy in a nationwide cohort study.
Cho YB, Park KS
Annals of surgical treatment and research 2026; (110(2)):84-91 doi:10.4174/astr.2026.110.2.84.
PMID: 41684630 - 8
Endogenous and Exogenous Thyrotoxicosis and Risk of Incident Cognitive Disorders in Older Adults.
Adams R, Oh ES, Yasar S, et al.
JAMA internal medicine 2023; (183(12)):1324-1331 doi:10.1001/jamainternmed.2023.5619.
PMID: 37870843 - 9
Subclinical hypothyroidism in older individuals.
Biondi B, Cappola AR
The lancet. Diabetes & endocrinology 2022; (10(2)):129-141 doi:10.1016/S2213-8587(21)00285-0.
PMID: 34953533 - 10
Diagnosis and treatment of hypothyroidism in the elderly.
Duntas LH, Yen PM
Endocrine 2019; (66(1)):63-69 doi:10.1007/s12020-019-02067-9.
PMID: 31482381 - 11
Semaglutide therapy and iatrogenic thyrotoxicosis.
Barnett MJL, Eidbo S, Rivadeneira A
Endocrinology, diabetes & metabolism case reports 2025; (2025(3)).
PMID: 40638337 - 12
Levothyroxine dose adjustment in hypothyroid patients following gastric sleeve surgery.
Richou M, Gilly O, Taillard V, et al.
Annales d'endocrinologie 2020; (81(5)):500-506 doi:10.1016/j.ando.2020.04.011.
PMID: 32445637 - 13
Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis.
Benvenga S, Capodicasa G, Perelli S, et al.
Frontiers in endocrinology 2018; (9()):150 doi:10.3389/fendo.2018.00150.
PMID: 29720960 - 14
Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption.
Gatta E, Bambini F, Buoso C, et al.
Frontiers in endocrinology 2022; (13()):1080108 doi:10.3389/fendo.2022.1080108.
PMID: 36561558 - 15
Reversible Thyroid Dysfunction Associated With Quetiapine Use in an Adolescent Patient: A Case Report.
Bandi PS, Qadri KU, Singh A, Elhag D
Cureus 2025; (17(6)):e86845 doi:10.7759/cureus.86845.
PMID: 40718313 - 16
Levothyroxine treatment and gastric juice pH in humans: the proof of concept.
Virili C, Bruno G, Santaguida MG, et al.
Endocrine 2022; (77(1)):102-111 doi:10.1007/s12020-022-03056-1.
PMID: 35477833 - 17
The effect of over- and undertreatment of hypothyroidism on hospitalization outcomes of patients with decompensated heart failure.
Kagansky D, Or K, Elkan M, et al.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2023; (71(6)):646-654 doi:10.1177/10815589231162542.
PMID: 36975306 - 18
Shared Decisionmaking in the Treatment of Hypothyroidism.
Bianco AC
Clinical endocrinology 2025; (103(1)):106-112 doi:10.1111/cen.15228.
PMID: 40077932
This page provides educational information on long-term hypothyroidism monitoring. Always consult your endocrinologist or primary care doctor before adjusting your thyroid medication or if you experience new symptoms.
Get notified when new evidence is published on hypothyroidism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.